Maxport India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.50 Cr
as on 23-10-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
as on 23-10-2024
- Revenue %
(FY 2023)
- Profit -8664.56%
(FY 2023)
- Ebitda -9515.28%
(FY 2023)
- Net Worth -21.98%
(FY 2023)
- Total Assets -31.17%
(FY 2023)
About Maxport India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raghav Mittal and Pooja Pandita serve as directors at the Company.
- CIN/LLPIN
U24232CH2013PTC034803
- Company No.
034803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maxport India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Pandita  | Director | 21-Dec-2015 | Current |
| Raghav Mittal | Director | 16-Oct-2021 | Current |
Financial Performance of Maxport India.
Maxport India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8664.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxport India?
In 2023, Maxport India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rosch Elmer Pharmaceuticals Private LimitedActive 13 years 8 monthsRaghav Mittal and Pooja Pandita are mutual person
- Interphar Healthcare Private LimitedActive 15 years 11 months
Raghav Mittal and Pooja Pandita are mutual person
- Searle Labs Private LimitedActive 15 years 11 months
Raghav Mittal and Pooja Pandita are mutual person
- Arvat Health Ventures Private LimitedActive 25 years 6 months
Raghav Mittal and Pooja Pandita are mutual person
- Swizinger Health Care Private LimitedActive 16 years 4 months
Raghav Mittal and Pooja Pandita are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 16 Jan 2014 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Maxport India?
Unlock and access historical data on people associated with Maxport India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxport India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxport India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
